Skip to main content
Home
  • Home
  • All Sites
  • Contact Us
User account menu
  • Log in

Welcome to the Surveillance After Resection of Oesophageal aNd Gastric cancer (SARONG) Trial

The SARONG study is looking at whether additional surveillance lead to early detection of cancer returning after surgery in patients with oesophageal or gastric cancer.
Learn more

 
Recruitment

952 patients (476 in each of two trial arms) will be recruited over a period of 32 months from approximately 24 sites in the UK.

Other useful info

CRUK website

ISRCTN website

HRA website

The ENSURE Study

 

 

Latest news

@SARONG_Trial

@sarongtrial.bsky.social

Recruitment Progress:

952
591

Date of latest recruit:

20 May, 2025

Site of latest recruit:

SARONG : Newcastle
  • University of Oxford logo
  • SITU and NDS Logo
  • NIHR Funded Logo

SARONG received Green Light in June 2023! 

FUNDER & SPONSOR

SARONG is sponsored by the University of Oxford

SARONG is funded by the NIHR Health Technology Assessment (HTA) Programme

SARONG is administreted by the Surgical Intervention Trials Unit (SITU) on behalf of Nuffield Department of Surgical Sciences

RESEARCH REFERENCE NUMBERS

Funder Reference: NIHR134344

Ethics Reference Number: 23/NW/0104

IRAS Number: 319230

Registry: ISRCTN 14417629

CPMS ID: 55905